Intracellular glutamate binding within the endoplasmic reticulum (ER) is thought to be necessary for plasma membrane expression of ionotropic glutamate receptors.
Here we determined the importance of glutamate binding to folding and assembly of soluble ligand-binding domains (LBDs), as well as fulllength receptors, by comparing the secretion of a soluble GluR6-S1S2 protein versus the plasma membrane localization of GluR6 kainate receptors following mutagenesis of the LBD. The mutations were designed to either eliminate glutamate binding, thereby trapping the bi-lobate LBD in an "open" conformation, or "lock" the LBD in a closed conformation with an engineered inter-domain disulfide bridge. Analysis of plasma membrane localization, media secretion of soluble LBD proteins, and measures of folding efficiency suggested that loss of glutamate binding affinity significantly impacted subunit protein folding and assembly. In contrast, receptors with conformationally restricted LBDs also exhibited decreased PM expression and altered oligomeric receptor assembly, but did not exhibit any deficits in subunit folding. Secretion of the closed LBD protein was enhanced compared to wild-type GluR6-S1S2. Our results suggest that glutamate acts as a chaperone molecule for appropriate folding of nascent receptors and that relaxation of LBDs from fully closed states during oligomerization represents a critical transition that necessarily engages other determinants within receptor dimers. Glutamate receptor LBDs therefore must access multiple conformations for efficient biogenesis.
Cellular control over the biogenesis and trafficking of ionotropic glutamate receptors (iGluRs) likely constitutes a major regulatory process that prevents aberrant excitatory neurotransmission within the central nervous system (CNS). Many receptor trafficking determinants are genetically encoded within the primary amino acid sequences of cytoplasmic carboxy-terminal domains (CTD) of iGluR subunits (1, 2) . Association of these determinants with accessory or chaperone proteins enhances forward transit from the ER, insertion into the plasma membrane (PM), synaptic targeting or a variety of other trafficking processes (3) (4) (5) (6) .
Ligand binding and gating domains upstream of CTDs also are critical in biogenesis of iGluRs (7) (8) (9) (10) (11) . Elucidating how these domains are engaged as quality-control checkpoints is essential to developing a comprehensive understanding of the neuronal mechanisms for control of excitatory transmission in the CNS.
Several recent studies have proposed that intracellular glutamate binding within the endoplasmic reticulum (ER) promotes proper folding and maturation of AMPA and kainate receptors and is required for forward trafficking of fully assembled receptors (10, (12) (13) (14) (15) . This hypothesis is based in large part on the observation that mutagenesis of key glutamate-binding LBD Conformational Changes Precede KAR Assembly 2 residues in the LBD greatly reduces or eliminates PM localization (7, 10, 12, 13) ; the mechanistic basis of this putative quality-control process is not understood. The critical receptor determinants involved in these cellular checkpoints could reside in the LBD, other regions that undergo glutamatedependent alterations in structure, or in intersubunit interactions associated with receptor desensitization (7) (8) (9) (10) 16) . It is possible that glutamate binding to iGluRs (and subsequent conformational rearrangements) act as tests of the functionality of fully assembled, export-ready receptors (8, 12, 16) ; alternatively, intact glutamatebinding sites may be required for earlier steps in receptor biogenesis, such as subunit folding and oligomeric assembly (7, 16) .
We tested here whether the glutamatedependent conformational changes critical to GluR6a KAR cell surface expression are restricted solely to the bi-lobate LBD, formed by the S1 and S2 segments of the receptor protein, or instead involve additional domains in the KAR subunits. Towards that end, we compared the effect of a LBD mutation that eliminated binding affinity for glutamate, T690A, on the efficiency of secretion of a soluble GluR6-S1S2 protein versus PM localization of the full-length receptor; this served as one way to test the autonomy of the LBD in quality-control processes, because soluble LBDs fold properly, form binding sites similar to those in the full-length receptor, and transit the secretory pathway to be released into culture media. Furthermore, we trapped LBDs of full-length receptors and soluble GluR6-S1S2 proteins in conformations that mimic closed, glutamate-bound states by introduction of a reversible, inter-domain (D1-D2) disulfide bond, allowing us to test the role of LBD relaxation or flexibility in assembly and trafficking. We found the ligand binding mutation resulted in reduced maturation and receptor surface expression in part through misfolding of the LBD. In addition, we found that locking the LBD into a closed state reduced receptor maturation and expression, but that this engaged regions outside of the LBD. While the locked, closed mutant also had assembly defects that occurred at the transition from dimers to tetramers, these did not result from apparent folding defects, suggesting that relaxation or opening of the LBD represents a critical step during oligomerization. In summary, we propose that LBDs must be able to access multiple conformations for efficient KAR biogenesis.
Experimental Procedures
Molecular Biology -All cDNAs were in pcDNA3 vectors.
Unedited myc-GluR6a(Q) cDNA was received from Dr. Christophe Mulle (Université Bordeaux II, France). cDNA for the soluble GluR6-S1S2 LBD protein was received from Mark Mayer (National Institutes of Health, Bethesda, MD) and the M3-S2 linker region, FLTVERMES (full-length receptor corresponding a.a. 627-635), was inserted N-terminal to the S2 sequence. This insertion was made to allow for the study of the potential role for the M3-S2 linker in LBD function in a previous study and was maintained for consistency of data (7) . Six c-myc epitopes were added C-terminal to the histidine codon of the signal peptide. For clarity, residues in the soluble S1S2 protein are referred to by the analogous amino acid in the full-length receptor. Amino acid numbering in the full-length receptor starts with the initiation methionine (8, 10) . All point mutations were made using the QuickChange site-directed mutagenesis protocol (Stratagene, LaJolla, CA) and were confirmed via DNA sequencing.
Cell Culture and Transfection -COS-7 cells (CRL-1651; American Type Culture Collection, Manassas, VA) and human embryonic kidney cells expressing T-antigen, clone 17 (HEK293-T/17) (CRL-11268) were cultured in DMEM supplemented with 100 µg/mL penicillin, 100 µg/mL streptomycin, and 10% heat-inactivated fetal bovine serum at 37°C with 5% CO 2 . Cells were fed every other day and split twice per week. 24 h prior to transfection, cells were plated at 3x10 4 cells/cm 2 in fresh medium. Cells were transfected with wild-type or mutant GluR6 cDNAs using Mirus Trans-IT transfection reagent (Mirus Bio Corporation, Madison, WI) at a ratio of 1 µg cDNA: 3 µL Trans-IT reagent and maintained in transfection medium until the completion of the assay.
ELISA -Cells in duplicate 12-well plates were transfected with 0.6 µg/well of cDNA. 48 h posttransfection cells were washed twice in ice-cold Dulbecco's phosphate buffered saline (DPBS) and fixed with 4% paraformaldehyde for 20 min at RT. After fixation, cells were washed three times in DPBS. For surface staining, fixed cells were then incubated in mouse α-c-myc antibody (1.6 µg/mL, LBD Conformational Changes Precede KAR Assembly 3 clone 9E10; Roche Applied Sciences) in 10% normal goat serum for 1 h at RT. For total staining, fixed cells were first permeabilized for 10 min at RT with 0.2% TX-100/DPBS, and then incubated with mouse α-c-myc antibody for 1 h at RT. Both groups were washed three times with DPBS and the incubated with HRP-conjugated goat α-mouse secondary antibody (1:1000, NA931V; GE Healthcare Biosciences, Buckinghamshire, UK) in 10% normal goat serum for 1 h at RT. Cells were again washed three times in DPBS and then incubated in the HRP substrate, SIGMAFAST OPD (P9187; Sigma, St. Louis, MO), for 1 h in the dark at RT. The optical density (O.D.) of 200 µL incubation medium was detected at 490 nm using a spectrophotometer. For experiments involving DTT treatment, at 32 h post-transfection, cells for both surface and total wells were incubated for 16 h with 1 mM DTT at 37°C in 5% CO 2 . All values were an average of triplicate samples from each well and the background absorbances from untransfected well O.D. readings were subtracted from each sample. Data are presented as a percentage of surface-tototal absorbance ratios.
Glycosidase Resistance Assay -Media from cells transfected 24 h with myc-GluR6-S1S2 cDNA was replaced with fresh media and incubated for an additional 24 h. From this media, 50 µg of myc-GluR6-S1S2 containing media were digested with no glycosidase, endoglycosidase H (EndoH, P0702S; New England Bio1abs, Ipswich, MA) or peptide N-glycosidase F (PNGaseF, P0704S; New England Biolabs) in provided reaction buffers for 1 h at 37°C according to manufacturer's protocol. These digested samples were then run on a 10% SDS-PAGE gel. Undigested and digested bands were detected with a mouse α-c-myc antibody (0.4 µg/mL; Roche Applied Sciences) and HRP-conjugated goat α-mouse secondary antibody (1:2000; GE Healthcare Biosciences). Densitometric analysis was carried out on the film using NIH ImageJ, and the data is represented as a ratio of the resistant band to the undigested band.
Electrophysiology -HEK293-T/17 cells were co-transfected with 0.2 µg of wild type or mutant myc-GluR6a cDNA and 0.05 µg of eGFP. 48 h post transfection, transfected cells were lifted from the cover slip and recorded in whole cell voltage clamp mode. Whole cell patch clamp recordings were performed as previously described (17 Crude homogenates were centrifuged for 20 min at 20,000 × g and the supernatant was collected as total cellular protein. 10 µg of protein were boiled for 10 min in 2X Laemmli buffer (161-0737; Biorad, Hercules, CA) and 350 mM β-mercaptoethanol (161-0710; Biorad), separated on a 7.5% SDS-PAGE gel and transferred overnight to a nitrocellulose membrane. Membranes were blocked in 5% non-fat dried milk in TBS-T [Tris buffered saline (TBS), pH 7.3 and 0.05% Tween 20 (P9416; Sigma)] for 2 h, washed twice in TBS-T and then incubated for 1-2 h at RT in mouse α-cmyc primary antibody (0.4 µg/mL; Roche Applied Sciences) diluted in blocking buffer. After washing, membranes were incubated in HRPconjugated goat α-mouse secondary antibody at RT for 1 h (1:5000; GE Healthcare Biosciences) diluted in blocking buffer. Membranes were washed and incubated for 5 min at RT in SuperSignal West Pico chemiluminescent substrate (Thermo Scientific, Rockford, IL). Densitometric analysis was performed using ImageJ software (National Institutes of Health).
Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE) -For analysis of receptor assembly, protein from transfected wells at 18 and 24 h post-transfection were collected as described above. Then samples were subjected to BN-PAGE as described (18) . Briefly, 10 µg of protein were loaded without boiling in 2X BN-PAGE loading buffer [final loaded solution containing 0.125% Coomassie Brilliant Blue G (B5133; Sigma), 10% glycerol, 0.01% bromophenol blue and 62.5 mM Tris (ph 6.8)] and separated on pre-cast non-SDS 4-15% Tris gels (161-1104; Biorad) for 45 min at 100 V, 45 min at 150 V and 200 V for 1 h at 4°C. The anode buffer contained 250 mM Tris base/1.92 M glycine and the cathode buffer was identical to the anode buffer plus 0.004% Coomassie Brilliant Blue G. Proteins were transferred overnight to a polyvinylidene difluoride membrane and the membranes were blocked in 5% non-fat dried milk in TBS-T overnight at 4°C. Membranes were washed twice in TBS-T and then incubated overnight in mouse α-c-myc primary antibody (0.2 µg/mL; Roche Applied Sciences) at 4°C. Following another three washes, membranes were incubated in HRP-conjugated goat α-mouse secondary antibody (1:4000) for 1 h at RT and analyzed using the same techniques as described for Western blots. Data are presented as a ratio of the optical densities for the oligomeric states of the mutant and wild-type myc-GluR6a(Q) receptors.
Fluorescence Recovery After Photobleaching (FRAP) -To measure the ER mobility of the GFP-GluR6a(Q), cells were plated in glass-bottom (no. 1.5) 35 mm dishes (P35G-1.5-14-C; Matek, Ashland, MA) and transfected with the respective GFP-tagged receptors. To disrupt the Golgi network, cells were incubated with brefeldin A for 4 h (2 µg/mL; Sigma) at 37°C in 5% CO 2 until imaging. At 48 h post-transfection, the media was switched to Hank's balanced salt solution (HBSS) with 15mm HEPES (pH 7.3) and cells were depleted of ATP by incubation for 60 min in 50 µM 2-deoxyglucose and 0.02% sodium azide at 37°C in 5% CO 2 as described previously (19) . Live cells expressing the GFP-tagged receptor were then subjected to photobleaching. Immediately prior to photobleaching, an image was captured of the live cell at 17.9% transmission of a 20 mW helium-neon laser at 70% power with a pinhole size of 3 Airy units on a Zeiss LSM 510 Meta confocal microscope (Carl Zeiss, Inc., Germany) within the Northwestern University Cell Imaging Facility. A small circular region of the same diameter was used for each cell and the area was photobleached by 50 iterations at 100% transmission. Immediately after photobleaching, another image was collected at 17.9% transmission and every 12 s thereafter until fluorescence within the photobleached area had reached a steady state level.
Analysis was performed using ImageJ software. Background was subtracted from each image in the series and fluorescence for both the photobleached region and the whole cell were collected at each time point. Cells were not included if the whole cell fluorescence did not reach an asymptote (i.e., continuous photobleaching occurred).
The following formulas, based on methodology described by Lippincott-Schwartz (20) , were used to calculate mobile fraction (M f ), fractional fluorescence (F f ) and the effective diffusion coefficient (D eff ):
where F precell is the whole cell pre-bleach fluorescence, F finalcell is the whole cell asymptote fluorescence, F postbleacharea is the fluorescence within the photobleached area immediately after photobleaching and F prebleacharea is the fluorescence within the photobleached area immediately prior to photobleaching. Data are expressed as a percentage of the GFP-tagged receptor that is mobile.
For fractional fluorescence:
where F(t) is the fluorescence within the photobleached area at time, t, F postbleacharea is as described above and F finalarea is the photobleached area asymptote fluorescence. Data were expressed as a percentage of final photobleached area fluorescence and were fit with a single exponential curve. Half-recovery time (t 1/2 ) was calculated as the time at which fluorescence reached half of the final fluorescence.
where r is the radius of the photobleached area in microns and t 1/2 is the half-recovery time in seconds (21). The D eff is an estimation and assumes 1) the area photobleached is circular and 2) movement only occurs in two dimensions.
Co-immunoprecipitation -48 h posttransfection, COS-7 cells plated in 100 mm dishes were lysed as described above and 500 µg of protein was pre-cleared by incubation overnight with 50 µL protein A/G-sepharose bead slurry (20421; Thermo Scientific) at 4°C with end-over-end mixing. The beads were spun down and the supernatant was incubated for 6-8 h at 4°C with 4 µg of rabbit α-calnexin (SPA-860; Assay Designs, Ann Arbor, MI) with mixing. 50 µL of protein A/G-sepharose bead slurry was added and the solution incubated with mixing overnight at 4°C. The beads were spun down and washed three times with lysis buffer. The beads were then boiled for 6 min in 50 µL of 2X Laemmli buffer and 15 µL of the eluate was separated on a 10% SDS-PAGE gel. 2 µg of lysate protein was loaded for each respective construct. Proteins were transferred, blocked and immunoblotted as described above. Optical densities for both the immunoprecipitated (IP) and lysate bands were measured and data were represented as percentage of the wild-type IP-to-lysate ratio.
Statistical Analysis -For data involving three or more groups, a one-way analysis of variance (ANOVA) was performed with a Tukey-Kramer post hoc test for comparison amongst the groups. For data involving two groups, an unpaired student's t-test was performed; if the standard deviations between the two groups were statistically significant, a Welsh correction was added. For analysis of oligomerization, a two-way ANOVA was performed with a Bonferroni post hoc test. Data are presented as mean ± S.E.M. with statistical significance set at p<0.05.
Results

Elimination of glutamate binding reduces
GluR6a receptor surface expression -Mutation of the agonist binding site results in reduced plasma membrane expression of AMPA and kainate receptors (10, 12, 13, 15, 16) .
Here we tested whether the subunit determinants responsible for this reduced surface expression reside solely within the LBD or involve other domains within kainate receptor subunits. To that end, we compared the PM expression of the full-length GluR6a receptor to the secretion of a soluble protein (GluR6-S1S2), for wild type and ligand binding deficient GluR6 receptors. Mutation of threonine 690 eliminates a key hydrogen bond between the side-chain hydroxyl group and the δ carbonyl oxygen in glutamate and other receptor ligands, thereby reducing PM expression (10, 12) . Similarly, we observed a significant reduction in the PM expression of GluR6a(T690A) (19.3 ± 6.0% of receptor protein was localized to the PM, n=7) when compared to the wild-type GluR6a (76.6 ± 8.9%, n=7, p<0.001) (Fig. 1A, lower  panel) . An analogous binding mutation in the soluble LBD protein, GluR6-S1S2(T690A), also reduced the relative secretion of the protein into the media, albeit to a lesser degree than the reduction observed with the full-length receptor (to 65.7 ± 8.1% of the wild-type GluR6-S1S2, n=5, p<0.05) (Fig. 1B, lower panel) . A similar reduction in secretion occurs with a ligand-binding deficient GluR4 LBD (15) 
An inter-domain disulfide bond in the LBD reduces PM expression of GluR6a receptors -In order to test the importance of flexibility of the binding domain in receptor biogenesis, the LBD was "locked" in a closed conformation through cysteine mutagenesis of two amino acids, E441 and N721, which form a critical inter-domain hydrogen bond in the closed, agonist-bound LBD. The proximity of the side-chains and their interaction in resolved, agonist-bound LBD structures suggested that an inter-domain disulfide bridge would form and restrict rotation (22) . A similar strategy was employed recently for GluR2 AMPA receptors (9) .
Plasma membrane expression of GluR6a(E441C/N721C) receptors was significantly lower than that of wild-type GluR6a receptors (27.8 ± 3.7%, n=14 versus 75.4 ± 3.9%, n=13, p<0.001) (Fig. 2A, lower panel) . Analogous mutations were made in the soluble S1S2 protein, but in contrast to the full-length receptor, GluR6-S1S2(E441C/N721C) protein was secreted to a greater degree into the media than wild-type GluR6-S1S2 protein (by 151.6 ± 11.9%, n=3) (Fig. 2B lower panel) . Thus, conformational restriction of the LBD with an intra-domain disulfide bridge prevents receptor plasma membrane expression but promotes secretion of soluble LBD protein.
Interactions between glutamate binding and disulfide mutants -Elimination of glutamate binding and introduction of the disulfide bond in the LBD had opposing effects on secretion of the soluble GluR6a-S1S2 protein, but both mutations reduced PM localization of full-length kainate receptors. We next determined which alteration dominated the expression phenotype in LBDs with both mutations, which could reveal if glutamate binding was required for formation of an interdomain disulfide bond. As expected, relative PM expression of a full-length receptor with all three mutations, GluR6a(E441C/T690A/N721C), was reduced significantly relative to wild-type GluR6a receptors (13.9 ± 2.8%, n=8, p<0.001 versus 76.6 ± 9.0%, n=7) to a level comparable to the GluR6a(T690A) mutant receptor (Fig. 3A, lower  panel) . In contrast, secretion of the soluble triple mutant, GluR6-S1S2(E441C/T690A/N721C) was similar to that of wild-type GluR6-S1S2 (normalized secretion 105.5 ± 12% of wild-type, n=4, not significant). This intermediate level was significantly more than the ligand binding mutant [GluR6-S1S2(T690A)] and less than the disulfide mutant [GluR6-S1S2(E441C/N721C)] protein secretion.
These data demonstrate that introduction of the disulfide bond alleviates the secretory deficit resulting from elimination of the glutamate binding site in the soluble S1S2 protein.
Glycosylation of LBD proteins -We also examined the glycosylation state of the soluble S1S2 proteins to determine if their altered secretion was correlated with changes in oligosaccharide processing.
Acquisition of resistance to the EndoH glycosidase, which cleaves immature oligosaccharide moieties, is a commonly used diagnostic assay to measure trafficking through the medial Golgi (10, (23) (24) (25) . Secreted S1S2 proteins were analyzed on Western blots following digestion in either control conditions (-), EndoH glycosidase (E) or PNGaseF (a glycosidase which cleaves both immature and mature oligosaccharide moieties) (P). Wild-type GluR6-S1S2 protein exhibited >50% resistance to EndoH digest, whereas oligosaccharides on both GluR6-S1S2(T690A) and GluR6-S1S2(E441C/N721C) LBDs were digested by EndoH to near-completion (25 ± 0.4% and 17 ± 0.9% resistance remaining, n=3 assays each, p<0.05) (Fig. 4) . Thus, oligosaccharide processing appeared uncorrelated with secretion of the soluble proteins.
Functional evidence for the formation of a inter-domain disulfide bond -We confirmed the presence of an inter-domain disulfide bond in whole-cell patch-clamp recordings from HEK293 T/17 cells transfected with either GluR6a or GluR6a(E441C/N721C) receptors. As shown in the representative traces in Figure 5A , 100 ms applications of 10 mM glutamate elicited large amplitude, rapidly desensitizing currents from wild-type GluR6a KARs (mean 13.5 ± 2.0 nA, n=4). Currents gated by GluR6a(E441C/N721C), in contrast, were <2% of the wild-type amplitude (231 ± 112 pA, n=5), consistent with combined functional and localization deficits. The marked attenuation of glutamate-evoked currents, which was much greater than predicted by the cell ELISAs ( Fig. 2A) , could have resulted from inaccessibility of the binding site in the presence of an inter-domain disulfide bond. Therefore, we co-applied 5 mM DTT with both external and glutamate solutions to reduce the disulfide bond; this treatment resulted in rapid potentiation of glutamate-evoked peak currents gated by the GluR6a(E441C/N721C) but not wild-type GluR6a receptors (potentiation from pre-DTT amplitudes of 928 ± 320% versus 110 ± 2%, respectively, n=4 and 5 recordings, p<0.05), confirming that the disulfide bond was present in the non-reduced receptor and occluded access of glutamate to the binding cleft. Interestingly, currents decreased rapidly to initial pre-application amplitudes following removal of DTT, suggesting that the inter-domain disulfide bond readily oxidized to restrict the LBDs.
We next tested if the reduced trafficking and membrane localization of GluR6a(E441C/N721C) receptors were reversible upon reduction of the disulfide bond. Receptor-expressing cells were cultured for 16 h in 1 mM DTT before cell ELISAs were performed to quantitate relative PM localization. DTT incubation had no effect on GluR6a relative PM expression (without DTT: 73.8 ± 2.6%, n=12; with DTT: 62.8 ± 8.0%, n=3) (Fig.  5B ). Surface expression of GluR6a(E441C/N721C) receptor, however, was significantly increased by DTT, from 27.8 ± 3.7% to 43.2 ± 5.0%, n=14 and 9, respectively, p<0.05). The triple mutant, GluR6a(E441C/T690A/N721C), did not exhibit the same increase with DTT (control, 10.2 ± 0.8%; DTT, 9.8 ± 1.7%, n=7 for each condition) (Fig.  5B) . Thus, membrane expression is enhanced by reduction of the inter-domain disulfide bond, consistent with a biogenic requirement for flexibility of the LBD.
Impact of the inter-domain disulfide bridge on oligomerization -Mutagenic restriction of the LBD Conformational Changes Precede KAR Assembly 7
LBD dynamics in the GluR6a(E441C/N721C) receptor could reduce PM expression through a number of mechanisms, including inefficient subunit folding, altered multimeric assembly, or a specific impact on receptor trafficking. Western blot analysis of membrane lysates revealed that GluR6a(E441C/N721C) subunit protein was expressed at dramatically lower levels than wildtype GluR6a subunits (Fig. 6A) . This was similarly observed in native PAGE analysis of oligomerization (Fig. 6B) . At 18 and 24 h posttransfection of COS-7 cells, wild-type GluR6a receptors were found in monomeric and tetrameric states, as was observed in a previous study (7) . In contrast, the small amount of GluR6a(E441C/N721C) receptor detectable at 18 h post-transfection is present as monomers and dimers. A similar stoichiometric distribution is observed at 24 h post-transfection -tetrameric bands were largely absent.
Quantitation of oligomeric bands via densitometry revealed that GluR6a(E441C/N721C) receptors exhibited a ~5-fold increase in the ratio of dimers to tetramers relative to GluR6a receptors (GluR6: 0.89 ± 0.1; GluR6a(E441C/N721C): 4.9 ± 2.7, n=3 assays, p<0.05) (Fig. 6B) . No significant difference was observed in the ratio of monomers to dimers. Therefore, the disulfide bridge impacts association of dimers during receptor assembly.
Analysis of receptor folding -We lastly assessed the impact of loss of glutamate binding or introduction of the inter-domain disulfide bridge on protein folding. In the first set of experiments, we measured the ER mobility of GFP-tagged GluR6a, GluR6a(T690A), and GluR6a(E441C/N721C) receptors using fluorescence recovery after photobleaching (FRAP) analysis, because misfolded proteins (including glutamate receptors) exhibit slower rates of diffusion in conditions of ATP depletion (19, 20) . We depleted transfected COS-7 cells of ATP via incubation with 2-deoxyglucose and then measured the time course of fluorescence recovery within photobleached areas of transfected cells (Fig.  7A) . GFP-GluR6a and GluR6a(E441C/N721C) receptors had similar recovery kinetics [GluR6a t 1/2 : 20.4 ± 1.9 s; GluR6a(E441C/N721C): 21.6 ± 1.7 s; n=12 and 13 cells analyzed, respectively] (Fig. 7B, C) , but GluR6a(T690A) recovered fluorescence significantly slower (30.5 ± 1.9 s, n=13, p<0.01) (Fig. 7B, C) . This slower recovery was reflected in a smaller estimated diffusion coefficient for GluR6a(T690A) (0.082 ± 0.006 µm 2 /s, n=13, p<0.05) compared to GluR6a and GluR6a(E441C/N721C) (0.110 ± 0.010 µm 2 /s and 0.113 ± 0.008 µm 2 /s, respectively) (Fig. 7D) . To ensure that this reduction in ER mobility was not the result of a reduced mobile receptor pool, we compared the mobile fractions for GluR6a, the ligand binding mutant and the disulfide locked mutant and found no difference amongst the three receptors (58.1 ± 2.6%, 55.6 ± 2.8%, and 56.1 ± 2.7%, n=13, 17, and 14, respectively) (Fig. 7E) .
As a second comparison of protein folding, we measured association of GluR6a(E441C/N721C) subunits with the folding-associated ER chaperone calnexin. Previously, GluR6a(T690A) receptors had increased association with this protein relative to wild-type GluR6a receptors, suggestive of receptor misfolding (7, 14) . Immunoprecipitations from transfected COS-7 cells were carried out with anti-calnexin antibody before immunoblotting for anti-myc immunoreactivity. In contrast to GluR6a(T690A), GluR6a(E441C/N721C) (81 ± 30%, n=3) receptors were not associated with calnexin to any greater degree than wild-type GluR6a receptors .
Calnexin association with S1S2 soluble proteins also was assayed to determine if alterations in secretion could be attributed to misfolding. Western blots and densitometric analysis of immunoprecipitated proteins revealed a significant increase in the amount of GluR6-S1S2(T690A) (by 255 ± 33%, n=3, p<0.01) associated with calnexin, relative to wild-type GluR6-S1S2 (Fig. 8AB) . No significant change from wildtype was observed with GluR6-S1S2(E441C/N721C) (144 ± 19%).
Taken together, these results support the hypothesis that decreased PM expression of the T690A mutant receptor in part results from misfolding of the LBD, whereas the decrease expression of the disulfide LBD mutant receptor is a consequence of defective assembly with no apparent folding deficits.
Discussion
Biogenesis and assembly of glutamate receptors are critical early determinants of ionotropic glutamate receptor function and subcellular localization. We show here that glutamate binding within the ER is essential for the proper folding of the GluR6a KAR ligand-binding domain.
Furthermore, these results demonstrate that relaxation from the closed, glutamate-bound conformation is necessary for assembly and trafficking of GluR6a, consistent with the hypothesis that GluR6a KARs undergo critical conformational transitions early in receptor assembly. These data support the hypothesis that key ER quality control checkpoints occur during subunit folding and oligomerization, prior to full assembly of export-competent KARs. The dimerto-tetramer transition could represent a common early biogenic checkpoint because assembly of AMPA and kainate receptors possessing defects in ligand binding (7, 10) , gating transitions (7,9) and conformationally restricted LBDs are impacted at this stage in biogenesis. The results of this study suggest that glutamate may act as a molecular chaperone necessary for the proper folding of the ligand-binding domain, and that ER quality control processes are engaged critically at an early stage of receptor biogenesis rather than on fullyassembled tetrameric receptors.
Glutamate binding: pre or post assembly checkpoint? -The importance of intracellular glutamate binding for PM expression was first shown for glutamate receptor analogues in C. elegans (13) . For mammalian AMPA and KA receptors elimination of glutamate binding reduces forward trafficking to the PM in heterologous cells and transfected neurons (10, (14) (15) (16) . In addition to glutamate binding, receptors blocked from entering a desensitized state (8) , that have altered desensitization kinetics (26) or are mutated at key dimerization residues (14, 26) have reduced cell surface expression. The inverse correlation of these physiological deficits and PM expression gave rise to the hypothesis that functionality of the nascent receptors was sampled by intracellular quality-control systems in the ER (2, 8, 14, 27) .
Based on our current results, we propose instead that reductions in PM localization can be accounted for in large part by subunit misfolding or inefficient oligomerization of receptors, rather than an intracellular test on functional, exportcompetent receptors. Changes to the LBD alone were sufficient to reduce PM expression, as both the full-length GluR6a(T690A) and the soluble GluR6-S1S2(T690A) protein had reduced PM expression and secretion, respectively (Fig. 1) . Also, the T690A LBD mutation reduced ATPdependent ER mobility (Fig.7) and increased association with the ER chaperone, calnexin (Fig.  8) , which suggests that glutamate, acting in a chaperone-like manner, is necessary for proper folding of the LBD. A similar form of liganddependent stabilization of folding intermediates of nascent proteins was postulated to occur during biogenesis of the vasopressin V 2 receptor, the δ opioid receptor and the NR1-1a NMDA receptor subunit (11, 28, 29) . The difference in the severity of the deficit between PM expression of the fulllength receptor and secretion of the soluble LBD with the ligand binding mutation could reflect additional conformational changes promoted by glutamate binding, such as exposure of residues involved in dimerization within the full-length receptor. GluR2 AMPAR ligand binding mutants exhibit increased misfolding and reduced forward trafficking (9) and a similar "chaperone-like" activity for glutamate binding was proposed recently for GluR4 AMPA receptors based on thermodynamic data that demonstrated increased structural stability of the LBD in the presence of glutamate (15, 30) .
In addition to compromising subunit folding, elimination of glutamate binding disrupts homooligomeric assembly of GluR6a KARs receptors (7) and might have an equivalent effect in AMPA receptors (2, 9, 27) . Mutations that alter receptor kinetics in AMPA and KARs (7, 9) as well as GluR2 receptors with reduced LBD interface stability (9), also negatively affect forward trafficking through increasing misfolding and, at least for GluR6a, disrupting receptor oligomerization at the dimer-to-tetramer transition (7) . Together, these data support the hypothesis that ER quality control engages AMPA and KAR early in receptor biogenesis with much of the observed reductions in PM expression attributed to defects at pre-tetrameric stages rather than on fully-assembled, functional receptors.
Multiple GluR6a conformational changes precede tetrameric assembly -Glutamate binding appears to be required for membrane expression for glutamate receptors (10, (14) (15) (16) , but the mechanistic basis for this phenomenon has been unclear. One possibility is that binding induces a specific conformational state, a closed LBD, permissive for ER exit. We tested this hypothesis by stabilizing the conformational state through by guest on April 29, 2016 http://www.jbc.org/ Downloaded from introduction of an inter-domain disulfide bond and measuring the effect on receptor trafficking. The results of this study suggested that an inflexible closed state is not the only conformational transition made in GluR6a receptor biogenesis and transit to the PM. Formation of the inter-domain disulfide bond reduced PM expression (Fig.2) and reduction of the disulfide bond partially reversed the trafficking phenotype (Fig 5) . In contrast to the glutamate binding mutant, the presence of the disulfide bond did not induce misfolding of the mutant receptor (Figs. 7 and 8 ), but did disrupt oligomeric assembly (Fig. 6) . Furthermore, we infer that conformational changes associated with relaxation from the glutamate-bound state involved domains other than the LBD, because secretion of soluble LBDs possessing the disulfide bond was increased relative to the wild-type soluble LBD (Fig. 2) despite possessing an immature glycosylation phenotype (Fig. 4) . This decrease in EndoH resistance could be a consequence of inaccessibility of the glycosylation sites in the restricted conformation. Consistent with these findings, an analogous inter-domain disulfide bond in the GluR2 AMPA receptor subunit, which restricted conformational changes, also reduced forward trafficking, but the folding and assembly properties of this mutant were not examined. (9) .
Functional impact of disulfide restriction of the GluR6 LBD -
The functional consequences of introducing the inter-domain disulfide bridge in GluR6a receptors contrasted with those observed upon analogous mutation of NMDA receptors. That is, dual cysteine mutation to create inter-domain disulfide bridges in NR1/NR2 heteromeric receptors produced constitutively active channels (31) . Disulfide-bonded mutant GluR6a receptors, however, gated very little current -much less than anticipated from the 30% surface expression measured in ELISAs. Reduction of the disulfide bond reversibly potentiated the glutamate-evoked currents by ~10-fold (Fig. 5) . Re-formation of the disulfide bridge appeared to be use-independent, because current amplitudes were diminished rapidly upon wash-out of DTT (data not shown), consistent with the idea that transient LBD closures occur in the absence of stabilizing ligand interactions. This physiological behavior could arise from several possible underlying mechanisms. First, the binding site might be occluded initially in the oxidized disulfide mutants, only becoming accessible as the reducing agent "unlocked" the receptors.
We note, however, that agonist application onto constitutively active NMDA receptors with analogous mutations increased currents, suggesting that the disulfide bond in that instance did not completely prevent agonist binding or dissociation (31) . Alternatively, the presence of the inter-domain disulfide bond in GluR6 might induce a highly desensitized state of the receptor (either with or without agonist bound), which would account for the small initial amplitude of currents. Application of DTT and reduction of the inter-domain disulfide bonds would permit recovery from desensitization, leading to the observed "potentiation" (Fig. 5) . Differences in the magnitude of basal desensitization induced by the disulfide bridge mutation in NMDA versus GluR6 KARs may account for the distinct physiological activities.
In conclusion, we determined that agonist binding is essential not only for the PM expression of GluR6a but also for the folding of the LBD itself. In addition, we show here that the LBD of GluR6a at least must undergo conformational relaxation for efficient assembly and trafficking of nascent GluR6a receptors to the PM, consistent with the model proposed for AMPA receptors (9) . Critical ER quality-control checkpoints occur early in receptor oligomeric assembly, at the dimer-to-tetramer transition, which is negatively impacted by several functionally relevant mutations (i.e., elimination of glutamate binding, altered desensitization and relaxation from a glutamate-bound state). Thus, appropriate biogenesis is assessed at multiple early stages by cellular systems that prevent aberrant iGluR expression and function. Diagram illustrating the domains of the full-length GluR6a receptor and the T690A ligand binding mutation. Bottom: Quantification of Cell ELISA data illustrating a reduction in PM expression resulting from the T690A LBD mutation (19.3 ± 6.0%, n=7 vs. 76.6 ± 8.9%, n=7, p<0.001). B. Top: Diagram illustrating the soluble GluR6-S1S2 protein with the T690A ligand binding mutation. Bottom: Quantification of western blots from GluR6-S1S2 media release experiments illustrating a reduction in release into media as a result of the T690A LBD mutation (65.7 ± 8.1%, n=5, p<0.05). FIGURE 2. An inter-domain disulfide bond across the LBD reduces PM expression of GluR6a receptors. A. Top: Diagram illustrating the full-length GluR6a receptor with the engineered disulfide bond. Bottom: Quantification of Cell ELISA data illustrating a reduction in PM expression resulting from the E441C/N721C mutation (27.8 ± 3.7%, n=14 vs. 75.4 ± 3.9%, n=13, p<0.001). B. Top: Diagram illustrating the soluble GluR6-S1S2 protein with the locked LBD mutation. Bottom: Quantification of western blots from GluR6-S1S2 media release experiments illustrating an increase in release into media as a result of the E441C/N721C LBD mutation (151.6 ± 11.9%, n=3, p<0.05). .0%, n=7, E441C/T690A/N721C: 13.9 ± 2.8%, n=8 vs. 76.6 ± 9.0%, n=7). B. Top: Diagram illustrating the soluble GluR6-S1S2 protein with both the T690A ligand binding mutation and the disulfide bond-forming LBD mutations. Bottom: Quantification of western blots from GluR6-S1S2 media release experiments illustrating an decrease in release with the T690A ligand binding mutation but no change in release into media as a result of the E441C/T690A/N721C mutations (T690A: 35.7 ± 3.4%, n=3, p<0.001, E441C/T690A/N721C: 105.5 ± 12%, n=4). Representative western blot (left) and quantification (right) of western blots from glycosidase resistance assays illustrating a reduced mature glycosylation of GluR6-S1S2(T690A) (0.25 ± 0.04, n=3, p<0.05) and GluR6-S1S2(E441C/N721C) (0.17 ± 0.1, n=3, p<0.05) relative to GluR6-S1S2 (0.59 ±0.1, n=3).
FIGURE 5. DTT application provides functional evidence for the formation of a inter-domain disulfide bridge.
A Representative traces (left) and quantitation (right) of whole cell peak currents elicited by a 100 ms application of 10 mM glutamate from wild-type GluR6a and GluR6a(E441C/N721C) reveal a significant potentiation of peak currents elicited with co-application of 5 mM DTT from GluR6a(E441C/N721C) when compared to wild-type GluR6a (928 ± 320%, n=4 vs. 110 ± 2%, n=5, p<0.05). B. Quantification of Cell ELISA data illustrating a selective and significant increase in PM expression of GluR6a(E441C/N721C) resultant from culturing in the presence of 1 mM DTT (E441C/N721C: 27.8 ± 3.7%, n=14 vs. 43.2 ± 5.0%, n=9, p<0.05, E441C/T690A/N721C: 10.2 ± 0.8%, n=7 vs. 9.8 ± 1.7%, n=7, GluR6a: 73.8 ± 2.6%, n=13 vs. 62.8 ± 8.0%, n=3). GluR6-S1S2 GluR6-S1S2 GluR6a receptors 
